World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
98
Citations
38559
World Ranking
784
National Ranking
70

Medicine

D-Index
98
Citations
38564
World Ranking
8878
National Ranking
863

Diego Vergani publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Diego Vergani sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 751 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Diego Vergani D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Diego Vergani sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 98 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Diego Vergani is affiliated with King's College London in the United Kingdom and has contributed extensively to the field of medicine, with a particular focus on hepatology. Their research encompasses the study of liver diseases, immunity, and the diagnosis and treatment of liver-related conditions.

The primary fields of study covered by Vergani's work include:

  • Medicine
  • Hepatology
  • Epidemiology
  • Surgery
  • Rheumatology
  • Pharmacology

Research topics addressed by Vergani extend to:

  • Liver Diseases and Immunity
  • Liver Disease Diagnosis and Treatment
  • Pediatric Hepatobiliary Diseases and Treatments
  • Systemic Lupus Erythematosus Research
  • Hepatitis B Virus Studies
  • Drug-Induced Hepatotoxicity and Protection
  • Drug Transport and Resistance Mechanisms

Vergani has published in several reputable venues, contributing frequently to:

  • Journal of Hepatology
  • Journal of Autoimmunity
  • Digestive and Liver Disease
  • Hepatology
  • Journal of Pediatric Gastroenterology and Nutrition

Among their recent papers are:

  • "Autoimmmune hepatitis" (2021), published in Cellular and Molecular Immunology
  • "Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report" (2023), published in Journal of Hepatology
  • "Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?" (2021), published in Journal of Autoimmunity
  • "Regulatory T cells in autoimmune hepatitis: an updated overview" (2021), published in Journal of Autoimmunity
  • "Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice" (2021), published in Clinical Reviews in Allergy & Immunology

Frequent collaborators in Vergani's work include:

  • Giorgina Mieli-Vergani
  • Benedetta Terziroli Beretta-Piccoli
  • Andreas Cerny
  • Yoh Zen
  • Maria Serena Longhi

Best Publications

  • International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

    F. Alvarez;P. A. Berg;F. B. Bianchi;L. Bianchi

  • Diagnosis and management of autoimmune hepatitis.

    Michael P. Manns;Albert J. Czaja;James D. Gorham;Edward L. Krawitt

  • The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

    Mala K. Maini;Carolina Boni;Chun Kyon Lee;Juan R. Larrubia

  • Autoimmune hepatitis in childhood : A 20-year experience

    G V Gregorio;B Portmann;F Reid;P T Donaldson

  • Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study

    Germana V. Gregorio;Bernard Portmann;John Karani;Phil Harrison

  • Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

    I. G. McFarlane;H. M. Smith;P. J. Johnson;G. P. Bray

  • Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

    George J.M. Webster;Stephanie Reignat;Mala K. Maini;Simon A. Whalley

  • INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B

    Antonina Smedile;Giorgio Verme;Antonietta Cargnel;Pietro Dentico

  • Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: Evidence that T cells are directed against HBV core antigen expressed on hepatocytes

    M Mondelli;G M Vergani;A Alberti;D Vergani

  • De-novo autoimmune hepatitis after liver transplantation

    Nanda Kerkar;Nedim Hadzic;Edward T Davies;Bernard Portmann

  • Autoimmune hepatitis

    Unknown

  • Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group.

    Diego Vergani;Fernando Alvarez;Francesco B. Bianchi;Eduardo L.R. Cançado

  • Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection

    Mala K. Maini;Carolina Boni;Graham S. Ogg;Abigail S. King

  • Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease

    Maria Serena Longhi;Yun Ma;Dimitrios P. Bogdanos;Paul Cheeseman

  • The importance of immune dysfunction in determining outcome in acute liver failure.

    Charalambos Gustav Antoniades;Philip A. Berry;Julia A. Wendon;Diego Vergani

  • Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.

    Maria Serena Longhi;Munther J. Hussain;Ragai R. Mitry;Sunil K. Arora

  • Autoimmune hepatitis – Update 2015

    Michael P. Manns;Ansgar W. Lohse;Diego Vergani

  • Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement.

    Giorgina Mieli-Vergani;Diego Vergani;Ulrich Baumann;Piotr Czubkowski

  • Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.

    Diego Vergani;Giorgina Mieli-Vergani;Alfredo Alberti;James Neuberger

  • Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions.

    Charlotte R. Grant;Rodrigo Liberal;Rodrigo Liberal;Giorgina Mieli-Vergani;Giorgina Mieli-Vergani;Diego Vergani;Diego Vergani

  • Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.

    Yun Ma;Manabu Okamoto;Mark G. Thomas;Dimitrios P. Bogdanos

  • The role of virus-specific CD8+cells in liver damage and viral control during persistent hepatitis B virus infection

    M K Maini;C Boni;K Lee;Larrubia

Frequent Co-Authors

Giorgina Mieli-Vergani
Giorgina Mieli-Vergani King's College London
Yun Ma
Yun Ma King's College London
Mark Peakman
Mark Peakman King's College London
Dimitrios P. Bogdanos
Dimitrios P. Bogdanos University Of Thessaly
Roger Williams
Roger Williams Foundation for Liver Research
Julia Wendon
Julia Wendon King's College London
Luigi Muratori
Luigi Muratori University of Bologna
Francesco B. Bianchi
Francesco B. Bianchi University of Bologna
Bernard Portmann
Bernard Portmann King's College London
Nigel Heaton
Nigel Heaton King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, related online degrees often include advanced nursing programs that provide a pathway to specialized healthcare roles. Accelerated options allow those with non-nursing backgrounds to quickly transition into nursing careers, making online accelerated nursing programs for non nurses a popular choice. These programs focus on equipping students with core clinical skills while allowing flexibility for working professionals.

Once in nursing, many professionals explore accelerated nurse practitioner program options to gain advanced practice credentials and increase their scope of practice. This can lead to specialized roles, such as moving from a family nurse practitioner to a more focused specialty. Understanding the process and requirements to transition from FNP to acute care NP is crucial for those seeking this career advancement.

Career outlooks in these fields are promising, with salary variations depending on the state. Reviewing the average DNP salary by state can help prospective students and professionals make informed decisions about relocation or salary expectations.

These related pathways highlight the diverse opportunities available for those studying Immunology in the USA, especially when coupled with nursing and healthcare expertise through recognized online programs.

Learn more about: dnp salary, fnp to acute care np, accelerated nurse practitioner program, and online accelerated nursing programs for non nurses.

Best Scientists Citing Diego Vergani

Trending Scientists

Recently Published Articles